Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death

Abraham, 1978, Influence of mouse age and erythrocyte age on glutathione metabolism, Biochem. J., 174, 819, 10.1042/bj1740819 Adams, 1991, Alzheimer's disease and Parkinson's disease: brain levels of glutathione, glutathione disulfide and vitamin E, Mol. Chem. Neuropathol., 14, 213, 10.1007/BF03159937 Ahlskog, 1997, Guamanian neurodegenerative disease: are diabetes mellitus and altered humoral immunity clues to pathogenesis?, Neurology, 48, 1356, 10.1212/WNL.48.5.1356 Ahlskog, 1995, Guamanian neurodegenerative disease: investigation of the calcium metabolism/heavy metal hypothesis, Neurology, 45, 1340, 10.1212/WNL.45.7.1340 Albin, 1992, Alternative excitotoxic hypotheses, Neurology, 42, 733, 10.1212/WNL.42.4.733 Andrews, 1967, Neurological disease on Guam: a review of past and present investigations, Bull. LA Neurol. Soc., 32, 30 Auer, 1988, Biological differences between ischemia, hypoglycemia and epilepsy, Ann. Neurol., 24, 699, 10.1002/ana.410240602 Bailey-Wilson, 1993, Potential role of an additive genetic component in the cause of amyotrophic lateral sclerosis and parkinsonism–dementia in the western pacific, Am. J. Med. Genet., 45, 68, 10.1002/ajmg.1320450118 Bains, 1992, Effect of propyl gallate feeding on glutathione content in aging Zaprionus paravittiger, Gerontology, 38, 192, 10.1159/000213327 Bakhit, 1981, Long-term effects of methamphetamine on the synthesis and metabolism of 5-hydroxytryptamine in various regions of the rat brain, Neuropharmacology, 20, 1135, 10.1016/0028-3908(81)90053-8 Balazs, 1994, Evidence of an oxidative challenge in the Alzheimer's brain, Neurochem. Res., 19, 1131, 10.1007/BF00965146 Ballard, 1985, Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases, Neurology, 35, 949, 10.1212/WNL.35.7.949 Bannai, 1984, Transport of cysteine and cystine in mammalian cells, Biochem. Biophys. Acta, 779, 289 Beal, 1992, Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?, Ann. Neurol., 31, 119, 10.1002/ana.410310202 Beal, 1992, Mechanisms of excitotoxicity in neurologic diseases, FASEB J., 6, 3338, 10.1096/fasebj.6.15.1464368 Beal, 1995, Aging, energy, and oxidative stress in neurodegenerative diseases, Ann. Neurol., 38, 357, 10.1002/ana.410380304 Beckman, 1993, ALS, SOD and peroxynitrite, Nature, 364, 584, 10.1038/364584a0 Behl, 1992, Vitamin E protects nerve cells from amyloid β protein toxicity, Biochem. Biophys. Res. Commun., 186, 944, 10.1016/0006-291X(92)90837-B Behl, 1994, Hydrogen peroxide mediates amyloid β protein toxicity, Cell, 77, 817, 10.1016/0092-8674(94)90131-7 G. Benzi (Ed.), Peroxidation, Energy Transduction and Mitochondria During Aging, John Libbey Eurotext, Paris, 1990. Benzi, 1995, Are reactive oxygen species involved in Alzheimer's disease?, Neurobiol. Aging, 16, 661, 10.1016/0197-4580(95)00066-N Benzi, 1995, Age- and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system, Free Rad. Biol. Med., 19, 77, 10.1016/0891-5849(94)00244-E G. Benzi, A. Moretti, Glutathione in brain aging and neurodegenerative disorders, in: C.A. Shaw (Ed.), Glutathione in the Nervous System, Taylor and Francis, Washington, DC, 1997, in press. Benzi, 1989, Age-related effect induced by oxidative stress on the cerebral glutathione system, Neurochem. Res., 14, 473, 10.1007/BF00964863 Benzi, 1988, Influence of aging and drug treatment on the cerebral glutathione system, Neurobiol. Aging, 9, 371, 10.1016/S0197-4580(88)80083-6 Birchall, 1988, Aluminium, chemical physiology, and Alzheimer's disease, Lancet, II, 1008, 10.1016/S0140-6736(88)90754-4 Boesgaard, 1994, Nitrate tolerance in vivo is not associated with depletion of arterial or venous thiol levels, Circ. Res., 74, 115, 10.1161/01.RES.74.1.115 Bolanos, 1995, Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurons and astrocytes in primary cultures, J. Neurochem., 64, 1965, 10.1046/j.1471-4159.1995.64051965.x Bonfoco, 1995, Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-d-aspartate or nitric oxide/superoxide in cortical cell cultures, Proc. Natl. Acad. Sci. USA, 92, 7162, 10.1073/pnas.92.16.7162 Bowling, 1993, Superoxide dismutase 1 with mutations linked to familial and sporadic amyotrophic lateral sclerosis, J. Neurochem., 61, 2322, 10.1111/j.1471-4159.1993.tb07478.x Braak, 1991, Neuropathological staging of Alzheimer-related changes, Acta Neuropathol., 82, 239, 10.1007/BF00308809 Brody, 1975, Patterns of amyotrophic lateral sclerosis and parkinsonism–dementia on Guam, Contemp. Neurol. Ser., 12, 45 Broquist, 1992, Buthionine sulfoximine, an experimental tool to induce glutathione deficiency and ascorbate in their role as antioxidants, Nutr. Rev., 50, 110, 10.1111/j.1753-4887.1992.tb01298.x Brown, 1995, Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice, Cell, 80, 687, 10.1016/0092-8674(95)90346-1 Buja, 1993, Apoptosis and necrosis: basic types and mechanisms of cell death, Arch. Pathol. Lab. Med., 117, 1208 Busciglio, 1995, Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro, Nature, 378, 776, 10.1038/378776a0 Butterfield, 1994, β-amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease, Biochem. Biophys. Res. Commun., 200, 710, 10.1006/bbrc.1994.1508 Calne, 1992, The free radical hypothesis in idiopathic parkinsonism: evidence against it, Ann. Neurol., 32, 799, 10.1002/ana.410320615 Candy, 1986, Aluminosilicates and senile plaque formation in Alzheimer's disease, Lancet, I, 354, 10.1016/S0140-6736(86)92319-6 I. Ceballos, F. Agid, A. Delacourte, A. Defossez, A. Nicole, P.M. Sinet, Parkinson's disease and Alzheimer's disease: neurodegenerative disorders due to brain antioxidant system deficiencies?, in: I. Emerit, L. Packer, C. Auclair (Eds.), Advances in Experimental Biology and Medicine: antioxidant in Therapy and Preventive Medicine, Plenum Press, New York, 1990, pp. 493–498. Ceballos-Picot, 1996, Peripheral antioxidant enzyme activities and selenium in elderly subjects and in dementia of Alzheimer's type—place of the extracellular glutathione peroxidase, Free Rad. Biol. Med., 20, 579, 10.1016/0891-5849(95)02058-6 Chance, 1979, Hydroperoxide metabolism in mammalian organs, Physiol. Rev., 59, 527, 10.1152/physrev.1979.59.3.527 Chandrasekaran, 1994, Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer's disease, Mol. Brain Res., 24, 336, 10.1016/0169-328X(94)90147-3 Chandrasekaran, 1992, Localization of cytochrome oxidase (COX) activity and COX mRNA in the hippocampus and entorhinal cortex of the monkey brain: correlation with specific neuronal pathway, Brain Res., 579, 333, 10.1016/0006-8993(92)90070-P Chao, 1995, Glia, cytokines, and neurotoxicity, Crit. Rev. Neurobiol., 9, 189 Charriaut-Marlangue, 1996, Apoptotic features of selective neuronal death in ischemia, epilepsy and gp 120 toxicity, Trends Neurosci., 19, 109, 10.1016/S0166-2236(96)80039-7 Chen, 1995, Disappearance of ALS from Guam: implications for exogenous causes (Japanese), Rinsho Shinkeigaku-Clin. Neurol., 35, 1549 Chen, 1989, The effect of aging on glutathione and cysteine levels in different regions of mouse brain, Proc. Soc. Exp. Biol. Med., 190, 399, 10.3181/00379727-190-42879 Chen, 1990, Life span profiles of glutathione and acetaminophen detoxification, Drug Metab. Dis., 18, 882 Chen, 1994, Protection by vitamin E, selenium, trolox C, ascorbic acid palmitate, acetylcysteine, coenzyme Q, beta-carotene, canthaxanthin, and (+)-catechin against oxidation damage to liver slices measured by oxidized heme proteins, Free Rad. Biol. Med., 16, 437, 10.1016/0891-5849(94)90120-1 Chen, 1996, Apo E and CYP2D6 polymorphism with and without parkinsonism–dementia complex in the people of Chamorro, Guam, Neurology, 47, 779, 10.1212/WNL.47.3.779 Choi, 1988, Glutamate neurotoxicity and diseases of the nervous system, Neuron, 1, 623, 10.1016/0896-6273(88)90162-6 Choi, 1990, The role of glutamate neurotoxicity in hypoxic–ischemic neuronal death, Ann. Rev. Neurosci., 13, 171, 10.1146/annurev.ne.13.030190.001131 Choi, 1995, Calcium: still center-stage in hypoxic–ischemic neuronal death, Trends Neurosci., 18, 58, 10.1016/0166-2236(95)93870-4 Colton, 1987, Production of superoxide anions by a CNS macrophage, the microglia, FEBS Lett., 223, 284, 10.1016/0014-5793(87)80305-8 A. Comfort, The Biology of Senescence, 3rd edn., Elsevier Science, New York, 1979. A.J.L. Cooper, Role of astrocytes in maintaining cerebral glutathione homeostasis and in protecting the brain against xenobiotics and oxidative stress, in: C.A. Shaw (Ed.), Glutathione in the Nervous System, Taylor and Francis, Washington, DC, 1997, in press. Coyle, 1993, Oxidative stress, glutamate, and neurodegenerative disorders, Science, 262, 689, 10.1126/science.7901908 M. Cudkowitz, R.A. Smith, R. Brown, Free radical toxicity in amyotrophic lateral sclerosis, in: C.A. Shaw (Ed.), Glutathione in the Nervous System, Taylor and Francis, Washington, DC, 1997, in press. M. Cuenod, K.Q. Do, Glutathione release and nitrosoglutathione presence in CNS implications for schizophrenia, in: C.A. Shaw (Ed.), Glutathione in the Nervous System, Taylor and Francis, Washington, DC, 1997, in press. de Belleroche, 1996, Amyotrophic lateral sclerosis: recent advances in understanding disease mechanism, J. Neuropathol. Exp. Neurol., 55, 747, 10.1097/00005072-199607000-00001 Deng, 1993, Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase, Science, 261, 1047, 10.1126/science.8351519 Den Hartog Jager, 1980, The distribution of Lewy bodies in the central and autonomic nervous systems in idiopathic paralysis agitans, J. Neurol. Neurosurg. Psychiatry, 23, 283, 10.1136/jnnp.23.4.283 Deneke, 1989, Regulation of cellular glutathione, Am. J. Physiol., 257, L163 Dexter, 1994, Indices of oxidative stress and mitochondrial function in individuals with incidental lewy body disease, Ann. Neurol., 35, 38, 10.1002/ana.410350107 Di Monte, 1991, Mitochondrial DNA and Parkinson's disease, Neurology, 41, 38, 10.1212/WNL.41.5_Suppl_2.38 D.A. Di Monte, P. Chan, M.S. Sandy, Glutathione in Parkinson's disease: a link between oxidative stress and mitochondrial damage? Ann. Neurol., (1992) S111–S115. Dragunow, 1994, Immediate-early gene protein expression in neurons undergoing delayed death but not necrosis, following hypoxia–ischemic injury to the young rat brain, Mol. Brain Res., 25, 19, 10.1016/0169-328X(94)90274-7 G. Dryhurst, Glutathione, cysteine and the neuromelanin pathway: potential roles in the pathogenesis of Parkinson's disease—a new hypothesis, in: C.A. Shaw (Ed.), Glutathione in the Nervous System, Taylor and Francis, Washington, DC, 1997. Duffy, 1965, Phase and electron microscopic observations of Lewy bodies and melanin granules in the substantia nigra and locus ceruleus in Parkinson's disease, J. Neuropath. Exp. Neurol., 24, 398, 10.1097/00005072-196507000-00003 Duncan, 1991, Role of the cycad neurotoxin βMAA in the amyotrophic lateral sclerosis–parkinsonism dementia complex of the western pacific, Adv. Neurol., 56, 301 Duncan, 1992, Zinc, a neurotoxin to cultured neurons, contaminates cycad flour prepared by traditional Guamanian methods, J. Neurosci., 12, 1523, 10.1523/JNEUROSCI.12-04-01523.1992 Dykens, 1987, Mechanisms of kainate toxicity to cerebellar neurons in vitro is analogous to reperfusion tissue injury, J. Neurochem., 49, 1222, 10.1111/j.1471-4159.1987.tb10014.x Dyrks, 1992, Amyloidogenicity of beta A4 and βA4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation, J. Biol. Chem., 267, 18210, 10.1016/S0021-9258(19)37174-1 Earnshaw, 1995, Apoptosis: lessons from in vitro systems, Trends Cell Biol., 5, 217, 10.1016/S0962-8924(00)89006-6 Ellis, 1991, Mechanisms and functions of cell death, Ann. Rev. Cell Biol., 7, 663, 10.1146/annurev.cb.07.110191.003311 Enayat, 1995, Two novel mutations in the gene for copper zinc superoxide dismutase in UK families with amyotrophic lateral sclerosis, Hum. Mol. Gen., 4, 1239, 10.1093/hmg/4.7.1239 Evans, 1989, Prevalence of Alzheimer's disease in a community population of older persons, JAMA, 262, 2551, 10.1001/jama.262.18.2551 Evans, 1993, Free radicals in brain metabolism and pathology, Br. Med. Bull., 49, 577, 10.1093/oxfordjournals.bmb.a072632 Evans, 1992, Aluminosilicate-induced free radical generation by murine brain glial cell in vitro: potential significance in the aetiopathogenesis of Alzheimer's dementia, Dementia, 3, 1 Evans, 1992, Oxidative damage in Alzheimer's dementia, and the potential etiopathogenic role of aluminosilicates, microglia and micronutrient interactions, EXS, 62, 178 Faber, 1982, Biology of disease: membrane injury and calcium homeostasis in the pathogenesis of coagulative necrosis, Lab. Invest., 47, 114 Fahn, 1992, The oxidant stress hypothesis in Parkinson's disease: evidence supporting it, Ann. Neurol., 32, 804, 10.1002/ana.410320616 Feany, 1996, Neuropathologic overlap of supranuclear palsy, pick's disease and corticobasal degeneration, J. Neuropathol. Exp. Neurol., 55, 53, 10.1097/00005072-199601000-00006 Figlewicz, 1994, The Cu/Zn superoxide dismutase gene in ALS and parkinsonism–dementia of Guam, Neuroreport, 5, 557, 10.1097/00001756-199401000-00006 L.S. Forno, Pathology of Parkinson's disease, in: C.D. Marsden, S. Fahn (Eds.), Movement Disorders, Neurology 2, Butterworth, London, 1981, pp. 21–40. Forno, 1987, Lewy bodies in Parkinson's disease, Adv. Neurol., 45, 35 Forno, 1996, Neuropathology of Parkinson's disease, J. Neuropathol. Exp. Neurol., 55, 259, 10.1097/00005072-199603000-00001 Fraga, 1990, Effect of aluminum on brain lipid peroxidation, Toxicol. Lett., 51, 213, 10.1016/0378-4274(90)90212-5 Frecker, 1990, Association between Alzheimer's disease and amyotrophic lateral sclerosis?, Can. J. Neurol. Sci., 17, 12, 10.1017/S0317167100029942 Fridovich, 1985, Superoxide dismutase: regularities and irregularities, Harvey Lect., 79, 51 Fujita, 1996, Decreased cytochrome c oxidase activity but unchanged superoxide dismutase and glutathione peroxidase activities in spinal cord of patients with amyotrophic lateral sclerosis, J. Neurosci. Res., 45, 276, 10.1002/(SICI)1097-4547(19960801)45:3<276::AID-JNR9>3.0.CO;2-A Garruto, 1980, Amyotrophic lateral sclerosis among Chamorro migrants from Guam, Ann. Neurol., 8, 612, 10.1002/ana.410080612 Garruto, 1985, Disappearance of high incidence amyotrophic lateral sclerosis and parkinsonism–dementia on Gaum, Neurology, 35, 193, 10.1212/WNL.35.2.193 Gerlach, 1994, Altered brain metabolism of iron as a cause of neurodegenerative diseases?, J. Neurochem., 63, 793, 10.1046/j.1471-4159.1994.63030793.x Gibb, 1988, The relevance of Lewy body to the pathogenesis of idiopathic Parkinson's disease, J. Neurol. Neurosurg. Psychiatry, 51, 745, 10.1136/jnnp.51.6.745 Gobe, 1994, Apoptosis in brain and gut tissue of mice fed a seed preparation of the cycad Lepidozamia perffskyana, Biochem. Biophys. Res. Comm., 205, 327, 10.1006/bbrc.1994.2668 Goedert, 1993, Tau protein and the neurofibrillary pathology of Alzheimer's disease, Trends Neurol. Sci., 16, 460, 10.1016/0166-2236(93)90078-Z Goedert, 1994, Risky apolipoprotein in brain, Nature, 372, 45, 10.1038/372045a0 Goldman, 1986, Cytoskeletal protein abnormalities in neurodegenerative diseases, Ann. Neurol., 19, 209, 10.1002/ana.410190302 Good, 1992, Neuromelanin containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study, Brain Res., 593, 343, 10.1016/0006-8993(92)91334-B Good, 1992, Selective accumulation of aluminum and iron in the neurofibrillar tangles of Alzheimer's disease: a laser microprobe (LAMMA) study, Ann. Neurol., 31, 286, 10.1002/ana.410310310 Goodman, 1994, Secreted forms of β-amyloid precursor protein protects hippocampal neurons against amyloid β-peptide-induced oxidative injury, Exp. Neurol., 128, 1, 10.1006/exnr.1994.1107 Gotz, 1994, Influence of N-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine, lipoic acid and l-deprenyl on the interplay between cellular redox systems, J. Neural. Transm., 43, 145 Gotz, 1992, Susceptibility of brains from patients with Alzheimer's disease to oxygen-stimulated lipid peroxidation and differential scanning calorimetry, Dementia, 3, 213 Graham, 1978, Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones, Mol. Pharmacol., 14, 633 Gsell, 1995, Decreased catalase activity but unchanged superoxide dismutase activity in brains of patients with dementia of Alzheimer type, J. Neurochem., 64, 1216, 10.1046/j.1471-4159.1995.64031216.x Guo, 1992, Glutathione: new candidate neuropeptide in the central nervous system, Neuroscience, 51, 835, 10.1016/0306-4522(92)90524-6 Gurney, 1994, Motor neuron degeneration that express a human Cu, Zn superoxide dismutase mutation, Science, 264, 1772, 10.1126/science.8209258 Gutteridge, 1985, Aluminium salts accelerate peroxidation of membrane lipids stimulated by iron salts, Biochim. Biophys. Acta, 835, 441, 10.1016/0005-2760(85)90113-4 Hagan, 1997, Parkinson's disease: prospects for improved drug therapy, Trends Pharmacol. Sci., 18, 156, 10.1016/S0165-6147(97)90612-X Hajimohammadreza, 1990, Brain membrane fluidity and lipid peroxidation in Alzheimer's disease, Neurosci. Lett., 112, 333, 10.1016/0304-3940(90)90226-Y Halliwell, 1992, Reactive oxygen species and central nervous system, J. Neurochem., 59, 1609, 10.1111/j.1471-4159.1992.tb10990.x Halliwell, 1996, Antioxidants in human health and disease, Ann. Rev. Nutr., 16, 33, 10.1146/annurev.nu.16.070196.000341 Halliwell, 1996, Cellular stress and protection mechanisms, Biochem. Soc. Trans., 24, 1023, 10.1042/bst0241023 Halliwell, 1997, Antioxidants and human disease: a general introduction, Nutr. Rev., 55, S44, 10.1111/j.1753-4887.1997.tb06100.x Halliwell, 1992, Free radicals, antioxidants, and human disease: where are we now?, J. Lab. Clin. Med., 119, 598 Harding, 1970, Free radical and protein-bound glutathione in normal and cataractous human lenses, Biochem. J., 117, 957, 10.1042/bj1170957 Harding, 1996, Glutathione in disease, Biochem. Soc. Trans., 24, 881, 10.1042/bst0240881 Harman, 1956, Aging: a theory based on free radical and radiation chemistry, J. Gerontol., 11, 298, 10.1093/geronj/11.3.298 Hazelton, 1980, Glutathione contents of tissues in the aging mouse, Biochem. J., 188, 25, 10.1042/bj1880025 Hazelton, 1983, Glutathione biosynthesis in the aging adult yellow-fever mosquito [(Aedes aegypti (Louisville)], Biochem J., 210, 289, 10.1042/bj2100289 Hazelton, 1984, Glutathione levels during the mosquito life span with emphasis on senescence, Proc. Soc. Exp. Biol. Med., 176, 249, 10.3181/00379727-176-41867 Heales, 1995, Depletion of brain glutathione is accompanied by impaired mitochondrial function and decreased N-acetyl aspartate concentration, Neurochem. Res., 20, 31, 10.1007/BF00995149 Hensley, 1994, A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease, Proc. Natl. Acad. Sci. USA, 91, 3270, 10.1073/pnas.91.8.3270 Hirata, 1995, Methamphetamine-induced serotonin neurotoxicity is mediated by superoxide radicals, Brain Res., 677, 345, 10.1016/0006-8993(95)00218-F Hixson, 1991, Apolipoprotein E polymorphisms affect atherosclerosis in young males, Arterioscler. Thromb., 11, 1237, 10.1161/01.ATV.11.5.1237 O.P. Hjelle, E. Rinvik, D. Huster, W. Reichelt, O.P. Ottersen, Antibodies to glutathione: production, characterization and immunocytochemical application to the central nervous system, in: C.A. Shaw (Ed.), Glutathione in the Nervous System, Taylor and Francis, Washington, DC, 1997, in press. Hockenbery, 1993, Bcl-2 functions in an antioxidant pathway to prevent apoptosis, Cell, 75, 241, 10.1016/0092-8674(93)80066-N F. Hucho, Transmitter receptors-general principles and nomenclature. in: F. Hucho (Ed.), Neurotransmitter Receptors, Elsevier Science, New York, 1993, pp. 3–59. Ince, 1994, Iron, selenium and glutathione peroxidase activity are elevated in sporadic motor neuron disease, Neurosci. Lett., 182, 87, 10.1016/0304-3940(94)90213-5 Jain, 1995, l-2-Oxothiazolidine-4-carboxylate, a cysteine precursor, stimulates growth and normalizes tissue glutathione concentrations in rats fed a sulfur amino acid-deficient diet, J. Nutr., 125, 851 Jain, 1991, Glutathione deficiency leads to mitochondrial damage in brain, Proc. Natl. Acad. Sci. USA, 88, 1913, 10.1073/pnas.88.5.1913 R. Janaky, V. Varga, Z.J. Jenei, P. Saransaari, S.S. Oja, Glutathione and glutathione derivatives: possible modulators of ionotropic glutamate receptors, in: C.A. Shaw (Ed.), Glutathione in the Nervous System, Taylor and Francis, Washington, DC, 1997, in press. Jeandel, 1989, Lipid peroxidation and free radical scavengers in Alzheimer's disease, Gerontology, 35, 275, 10.1159/000213037 Jenner, 1993, Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease, Acta Neurol. Scan., 87, 6, 10.1111/j.1600-0404.1993.tb00013.x Jenner, 1996, Oxidative stress and the pathogenesis of Parkinson's disease, Neurology, 47, S161, 10.1212/WNL.47.6_Suppl_3.161S Jenner, 1992, Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental lewy body disease, Ann. Neurol., 32, S82, 10.1002/ana.410320714 Joachim, 1992, The seminal role of β-amyloid in the pathogenesis of Alzheimer's disease, Alz. Disord. Ass. Dis., 6, 7, 10.1097/00002093-199205000-00003 Jones, 1995, Variability in glutathione-dependent detoxification in vivo and its relevance to detoxification of chemical mixtures, Toxicology, 105, 267, 10.1016/0300-483X(95)03221-Z Jones, 1992, Glutathione in foods listed in the national cancer institute's health habits and history food frequency questionnaire, Nutr. Cancer, 17, 57, 10.1080/01635589209514173 Joseph, 1992, Cholinergic systems in aging: the role of oxidative stress, Clin. Neuropathol., 15, 508A Julius, 1994, Glutathione and morbidity in a community-based sample of elderly, J. Epidemiol., 47, 1021, 10.1016/0895-4356(94)90117-1 Kalra, 1996, Lewy body disease and dementia, Arch. Intern. Med., 156, 487, 10.1001/archinte.156.5.487 Kane, 1993, Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species, Science, 262, 1274, 10.1126/science.8235659 Kannan, 1990, Evidence for carrier-mediated transport of glutathione across the blood–brain barrier in the rat, J. Clin. Invest., 85, 2009, 10.1172/JCI114666 R. Kannan, J.-R. Yi, B.V. Zlokovic, N. Kaplowitz, Carrier-mediated GSH transport at the blood brain barrier and molecular characterization of novel brain GSH transporters, in: C.A. Shaw (Ed.), Glutathione in the Nervous System, Taylor and Francis, Washington, DC, 1997, in press. H. Kappus, Biochemical mechanisms of chemical induced lipid peroxidation, in: C. Vigo-Pelfry (Ed.), Membrane Lipid Oxidation, CRC Press, Boca Raton, FL, 1991. Kass, 1989, Activation of hepatocyte protein kinase C by redox-cycling quinones, Biochem. J., 260, 499, 10.1042/bj2600499 Katayama, 1988, Increase in extracellular glutamate and associated massive ionic fluxes following concussive brain injury, Neurosci. Abstr., 14, 1154 Keller, 1997, 4-hydroxynonenal, an aldehyde product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes, Neuroscience, 80, 685, 10.1016/S0306-4522(97)00065-1 Keller, 1997, Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid β-peptide: role of the lipid peroxidation product 4-hydroxynonenal, J. Neurochem., 69, 273, 10.1046/j.1471-4159.1997.69010273.x Ketterer, 1988, Protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis, Mut. Res., 202, 343, 10.1016/0027-5107(88)90197-2 Kisby, 1992, Content of the neurotoxin cycasin (methylazoxymethanol beta-d-glucoside) and βMAA (beta-N-methylamino-l-alanine) in cycad flour prepared by Guam Chamorros, Neurology, 42, 1336, 10.1212/WNL.42.7.1336 Kish, 1992, Brain cytochrome oxidase in Alzheimer's disease, J. Neurochem., 59, 776, 10.1111/j.1471-4159.1992.tb09439.x Kish, 1992, Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson's disease, J. Neurochem., 58, 642, 10.1111/j.1471-4159.1992.tb09766.x Koh, 1988, Zinc alters excitatory amino acid neurotoxicity on central neurons, J. Neurosci., 8, 2164, 10.1523/JNEUROSCI.08-06-02164.1988 Kostic, 1997, Midbrain dopaminergic degeneration in a transgenic mouse model of familial amyotrophic lateral sclerosis, Ann. Neurol., 41, 497, 10.1002/ana.410410413 Krieger, 1993, Activation of PKC reverses apparent NMDA receptor reduction in ALS, Neuroreport, 4, 931, 10.1097/00001756-199307000-00023 Krieger, 1996, Amyotrophic lateral sclerosis: the involvement of intracellular Ca+2 and protein kinase C, Trends Pharmacol. Sci., 17, 114, 10.1016/0165-6147(96)10004-3 L.T. Kurland, K. Radhakrishnan, D.B. Williams, S.C. Waring, Amyotrophic lateral sclerosis–parkinsonism–dementia complex on Guam: epidemiologic and etiological perspectives, in: A. Williams (Ed.), Motor Neuron Disease, Chapman & Hall, London, 1994, pp. 109–130. Lang, 1992, Low blood glutathione levels in healthy aging adults, J. Lab. Clin. Med., 120, 720 Lang, 1989, Blood glutathione: a biochemical index of life span enhancement in the diet restricted Lobund–Wistar rats, Prog. Clin. Biol. Res., 287, 241 Langaniere, 1989, Effect of chronic food restriction in aging rats: II. Liver cytosolic antioxidants and related enzymes, Mech. Ageing Dev., 48, 221, 10.1016/0047-6374(89)90084-5 J.W. Langston, MPTP: the promise of a new neurotoxin, in: C.D. Marsden, S. Fahn (Eds.), Movement Disorders 2, Butterworth, London, 1987, pp. 73–90. Lanius, 1993, Increased [35S] glutathione binding sites in spinal cords from patients with amyotrophic lateral sclerosis, Neurosci. Lett., 163, 89, 10.1016/0304-3940(93)90236-E Lanius, 1995, A role for amplified protein kinase C activity in the pathogenesis of amyotrophic lateral sclerosis, J. Neurochem., 65, 927, 10.1046/j.1471-4159.1995.65020927.x Lanius, 1994, Characterization, distribution, and protein kinase C-mediated regulation of [35S] glutathione binding sites in mouse and human spinal cord, J. Neurochem., 63, 155, 10.1046/j.1471-4159.1994.63010155.x Lassmann, 1995, Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ, Acta Neuropathol., 89, 35, 10.1007/BF00294257 Lavine, 1991, Amyotrophic lateral sclerosis/parkinsonism–dementia complex in Southern Guam: is it disappearing?, Adv. Neurol., 56, 271 F.H. Lewy, Paralysis agitans: I. Pathologische anatomie, in: M. Lewandowsky (Ed.), Handbuch der Neurologie, Springer, New York, 1912, pp. 920–933. Li, 1997, A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion, Neuron, 19, 453, 10.1016/S0896-6273(00)80953-8 Lin, 1992, Detection of point mutations in codon 331 of mitochondrial NADH dehydrogenase subunit 2 in Alzheimer's brains, Biochem. Biophys. Res. Comm., 182, 238, 10.1016/S0006-291X(05)80136-6 Lomaestro, 1995, Glutathione in health and disease: pharmacotherapeutic issues, Ann. Phamacother., 29, 1263, 10.1177/106002809502901213 Loo, 1993, Apoptosis is induced by β-amyloid in cultured central nervous system neurons, Proc. Natl. Acad. Sci. USA, 99, 7951, 10.1073/pnas.90.17.7951 Lorenzo, 1994, β-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red, Proc. Natl. Acad. Sci. USA, 91, 12243, 10.1073/pnas.91.25.12243 Louvel, 1997, Therapeutic advances in amyotrophic lateral sclerosis, Trends Pharmacol. Sci., 18, 196, 10.1016/S0165-6147(97)01062-6 Lovell, 1995, Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease, Neurology, 45, 1594, 10.1212/WNL.45.8.1594 Lucas, 1957, The toxic effect of sodium l-glutamate on the inner layers of the retina, AMA Arch. Ophthal., 58, 193, 10.1001/archopht.1957.00940010205006 Mahley, 1988, Apolipoprotein E: cholesterol transport protein with expanding role in cell biology, Science, 240, 622, 10.1126/science.3283935 Makar, 1995, Carnitine, carnitine acetyltransferase, and glutathione in Alzheimer brain, Neurochem. Res., 20, 705, 10.1007/BF01705539 Maker, 1994, Vitamin E, ascorbate, glutathione, glutathione disulfide and enzymes of glutathione metabolism in cultures of chick astrocytes and neurons: evidence that astrocytes play an important role in the antioxidative processes in the brain, J. Neurochem., 62, 45, 10.1046/j.1471-4159.1994.62010045.x H. Mann, M.T. McCoy, J. Subramaniam, H.V. Remmen, J.L. Cadet, Overexpression of superoxide dismutase and catalase in immortalized neural cells: toxic effects of hydrogen peroxide, Brain Res. (1997), in press. Mark, 1995, Amyloid beta-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca+2 homeostasis and cell death, J. Neurosci., 15, 6239, 10.1523/JNEUROSCI.15-09-06239.1995 Mark, 1997, A role for 4-hydroxynonenal, an aldehyde product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide, J. Neurochem., 68, 255, 10.1046/j.1471-4159.1997.68010255.x Mark, 1997, Amyloid β-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation, J. Neurosci., 17, 1046, 10.1523/JNEUROSCI.17-03-01046.1997 Markesberry, 1997, Oxidative stress hypothesis in Alzheimer's disease, Free Rad. Biol. Med., 23, 134, 10.1016/S0891-5849(96)00629-6 Marklund, 1990, Expression of extracellular superoxide dismutase by human cell lines, Biochem. J., 266, 213, 10.1042/bj2660213 Martensson, 1993, Glutathione ester delays the onset of scurvy in ascorbate-deficient guinea pigs, Proc. Natl. Acad. Sci. USA, 90, 317, 10.1073/pnas.90.1.317 Martensson, 1991, Inhibition of glutathione synthesis in the newborn rat: a model for endogenously produced oxidative stress, Proc. Natl. Acad. Sci. USA, 88, 9360, 10.1073/pnas.88.20.9360 Martensson, 1991, Glutathione deficiency decreases tissue ascorbate levels in newborn rats: ascorbate spares glutathione and protects, Proc. Nat. Acad. Sci. USA, 88, 4656, 10.1073/pnas.88.11.4656 C.N. Martyn, Epidemiology, in: A.C. Williams (Ed.), Motor Neuron Disease, Chapman & Hall, London, 1994, pp. 393–426. Mattson, 1995, Free radicals and disruption of neuronal ion homeostasis in AD: a role for amyloid β-peptide?, Neurobiol. Aging, 16, 679, 10.1016/0197-4580(95)00063-K Mattson, 1993, β-amyloid precursor protein metabolites and loss of neuronal Ca+2 homeostasis in Alzheimer's disease, Trends Neurosci., 16, 409, 10.1016/0166-2236(93)90009-B Mattson, 1995, Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium, Brain Res., 676, 219, 10.1016/0006-8993(95)00148-J M.D. Mattson, B. Rychlik, M.G. Engle, Possible involvement of calcium and inositol phospholipid signaling pathways in neurofibrillary degeneration, in: K. Iqbal, D.R.C. McLachlan, B. Winblad, H.M. Wisnieski (Eds.), Alzheimer's Disease: Basic Mechanisms, Diagnosis and Therapeutic Strategies, Wiley, New York, 1990, pp. 191–198. McEachern, 1996, An alternative to LTP orthodoxy: a plasticity-pathology continuum model, Brain Res. Rev., 22, 51, 10.1016/0165-0173(96)00006-9 McGeer, 1997, Familial nature and continuing morbidity of the amyotrophic lateral sclerosis–parkinsonism dementia complex of Guam, Neurology, 49, 400, 10.1212/WNL.49.2.400 McLachlan, 1996, Risk for neuropathologically confirmed Alzheimer's disease and residual aluminum in municipal drinking water employing weighted residential histories, Neurology, 46, 401, 10.1212/WNL.46.2.401 Mecocci, 1993, Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain, Ann. Neurol., 34, 609, 10.1002/ana.410340416 Meiri, 1991, Aluminum ingestion—is it related to dementia?, Rev. Environ. Health, 9, 191, 10.1515/REVEH.1991.9.4.191 Meister, 1988, Glutathione metabolism and its selective modification, J. Biol. Chem., 263, 17205, 10.1016/S0021-9258(19)77815-6 A. Meister, On the biochemistry of glutathione, in: N. Taniguchi, T. Higashi, Y. Sakamoto, A. Meister (Eds.), Glutathione Centennial: Molecular Perspectives and Clinical Implications, Academic Press, San Diego, 1989, pp. 3–21. Meister, 1994, Glutathione–ascorbic acid antioxidant system in animals, J. Biol. Chem., 269, 9397, 10.1016/S0021-9258(17)36891-6 Meldrum, 1990, Excitatory amino acid neurotoxicity and neurodegenerative disease, Trends Pharmacol. Sci., 11, 379, 10.1016/0165-6147(90)90184-A Minauf, 1969, Kombination von amyotrophischer lateralsklerose mit pickscher krankeit, Arch. Psychiat. Nervenkr., 212, 279, 10.1007/BF00341577 Mithofer, 1992, Mitochondrial poisons cause depletion of reduced glutathione in isolated hepatocytes, Arch. Biochem. Biophys., 295, 132, 10.1016/0003-9861(92)90498-L Miyamoto, 1990, Idebenone attenuates neuronal degeneration induced by intrastriatal injection of excitotoxins, Exp. Neurol., 108, 38, 10.1016/0014-4886(90)90005-D Miyamoto, 1989, Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line, J. Pharmacol. Exp. Ther., 250, 1132 Mitchell, 1973, Acetaminophen-induced hepatic necrosis: IV. Protective role of glutathione, J. Pharmacol. Exp. Ther., 187, 211 Montine, 1997, Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of apoE4, Am. J. Pathol., 150, 437 Monyer, 1990, 21-Aminosteroids attenuate excitotoxic neuronal injury in cortical cell cultures, Neuron, 5, 121, 10.1016/0896-6273(90)90302-V Multhaup, 1997, Reactive oxygen species and Alzheimer's disease, Biochem. Pharmacol., 54, 533, 10.1016/S0006-2952(97)00062-2 Munch, 1997, Advanced glycation end products in ageing and Alzheimer's disease, Brain Res. Rev., 23, 134, 10.1016/S0165-0173(96)00016-1 Mutisya, 1994, Cortical cytochrome oxidase activity is reduced in Alzheimer's disease, J. Neurochem., 63, 2179, 10.1046/j.1471-4159.1994.63062179.x L.S. Myers, Free radical damage to nucleic acids and their components: the direct absorption of energy, in: W.A. Pryor (Ed.), Free radicals in Biology, Vol. 4, Academic Press, New York, 1980, pp. 95–114. Nagata, 1997, Apoptosis by death factor, Cell, 88, 355, 10.1016/S0092-8674(00)81874-7 Nicholson, 1995, Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis, Nature, 376, 37, 10.1038/376037a0 Novelli, 1988, Glutamate becomes neurotoxic via the N-methyl-d-aspartate receptor when intracellular energy levels are reduced, Brain Res., 451, 205, 10.1016/0006-8993(88)90765-2 Ogita, 1995, A possible role of glutathione as an endogenous agonist at the N-methyl-d-aspartate recognition domain in rat brain, J. Neurochem., 64, 1088, 10.1046/j.1471-4159.1995.64031088.x K. Ogita, M. Shuto, H. Maeda, T. Minami, Y. Yoneda, Possible modulation by glutathione of glutamatergic neurotransmission, in: C.A. Shaw (Ed.), Glutathione in the Nervous System, Taylor and Francis, Washington, DC, 1997, in press. Oh, 1995, Screening for non-protein amino acids in seeds of the Guam cycad, Cycas circinalis, by an improved GC-MS method, Planta Med., 61, 66, 10.1055/s-2006-958002 Ohyashiki, 1993, Stimulation of Fe2+-induced lipid peroxidation in phosphatidylcholine liposomes by aluminium ions at physiological pH, Biochim. Biophys. Acta, 1170, 182, 10.1016/0005-2760(93)90069-L Okabe, 1989, Calmodulin and free radicals interaction with steady-state calcium accumulation and passive calcium permeability of cardiac sarcoplasmic reticulum, J. Pharmacol. Exp. Ther., 250, 286 Olanow, 1990, Oxidation reactions in Parkinson's disease, Neurology, 40, 32 Olanow, 1992, An introduction to the free radical hypothesis in Parkinson's disease, Ann. Neurol., 32, S2, 10.1002/ana.410320703 Olanow, 1997, Attempts to obtain neuroprotection in Parkinson's disease, Neurology, 49, S26, 10.1212/WNL.49.1_Suppl_1.S26 Olanow, 1989, MR images in Parkinson's disease and aging, Adv. Neurol., 36, 155 J.W. Olney, Neurotoxicity of excitatory amino acids, in: E.G. McGeer, J.W. Olney, P.L. McGeer (Eds.), Kainic Acid As a Tool in Neurobiology, Raven Press, New York, 1978, pp. 1–15. Olney, 1990, l-Cysteine, a bicarbonate-sensitive endogenous excitotoxin, Science, 248, 596, 10.1126/science.2185543 Orrenius, 1992, Calcium ions and oxidative cell injury, Ann. Neurol., 32, S33, 10.1002/ana.410320708 Oteiza, 1994, A mechanism for the stimulatory effect of aluminum on iron-induced lipid peroxidation, Arch. Biochem. Biophys., 308, 374, 10.1006/abbi.1994.1053 Parker, 1989, Abnormalities of the electron transport chain in idiopathic Parkinson's disease, Ann. Neurol., 26, 719, 10.1002/ana.410260606 Parker, 1990, Cytochrome oxidase deficiency in Alzheimer's disease, Neurology, 40, 1302, 10.1212/WNL.40.8.1302 Parker, 1994, Electron transport chain defects in Alzheimer's disease brain, Neurology, 44, 1090, 10.1212/WNL.44.6.1090 1995, Cerebrospinal fluid homovanillic acid in the DATATOP study on Parkinson's disease, Arch. Neurol., 52, 237, 10.1001/archneur.1995.00540270025015 1996, Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP subjects not requiring levodopa, Ann. Neurol., 39, 29, 10.1002/ana.410390106 1996, Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa, Ann. Neurol., 39, 37, 10.1002/ana.410390107 B.A. Pasqualotto, K. Curry, C.A. Shaw, Excitatory actions of GSH on neocortex, in: C.A. Shaw (Ed.), Glutathione in the Nervous System, Taylor and Francis, Washington, DC, 1997, in press. Pasqualotto, 1996, Regulation of ionotropic receptors by protein phosphorylation, Biochem. Pharmacol., 51, 1417, 10.1016/0006-2952(95)02405-0 Patel, 1997, A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes, J. Biol. Chem., 272, 10.1074/jbc.272.32.20185 Pelech, 1996, Kinase connections on the cellular intranet: signalling pathways, Curr. Biol., 6, 551, 10.1016/S0960-9822(02)00540-7 Perrin, 1990, Blood activity of Cu/Zn superoxide dismutase, glutathione peroxidase and catalase in Alzheimer's disease: a case-control study, Gerontology, 36, 306, 10.1159/000213215 Perry, 1982, Parkinson's disease: a disorder due to nigral glutathione deficiency, Neurosci. Lett., 33, 300, 10.1016/0304-3940(82)90390-1 Perry, 1988, Brain amino acids and glutathione in progressive supranuclear palsy, Neurology, 38, 943, 10.1212/WNL.38.6.943 Perry, 1986, Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients, Neurosci. Lett., 67, 269, 10.1016/0304-3940(86)90320-4 Perry, 1987, Amino acids, glutathione, and glutathione transferase activity in the brains of patients with Alzheimer's disease, Ann. Neurol., 21, 331, 10.1002/ana.410210403 Peuchen, 1997, Interrelationships between astrocyte function, oxidative stress and antioxidant status within the central nervous system, Prog. Neurobiol., 52, 261, 10.1016/S0301-0082(97)00010-5 Pike, 1993, Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state, J. Neurosci., 13, 1676, 10.1523/JNEUROSCI.13-04-01676.1993 Poirier, 1993, Apolipoprotein E polymorphism and Alzheimer's disease, Lancet, 342, 697, 10.1016/0140-6736(93)91705-Q Portera-Cailliau, 1995, Evidence for apoptotic cell death in Huntington's disease and excitotoxic animal models, J. Neurosci., 15, 3775, 10.1523/JNEUROSCI.15-05-03775.1995 Price, 1987, Ciba Found. Symp., 126, 30 Przedborski, 1996, Brain superoxide dismutase, catalase, and glutathione peroxidase activities in amyotrophic lateral sclerosis, Ann. Neurol., 39, 158, 10.1002/ana.410390204 Przedborski, 1992, Superoxide dismutase, catalase and glutathione peroxidase activities in copper/zinc–superoxide dismutase transgenic mice, J. Neurochem., 58, 1760, 10.1111/j.1471-4159.1992.tb10051.x Przedborski, 1996, Blood superoxide dismutase, catalase and glutathione peroxidase activities in familial and sporadic amyotrophic lateral sclerosis, Neurodegeneration, 5, 57, 10.1006/neur.1996.0008 Puttfarcken, 1993, Kainic acid induced lipid peroxidation: protection with butylated hydroxytoluene and U 78517F in primary culture of cerebellar granule cells, Brain Res., 624, 223, 10.1016/0006-8993(93)90081-W Rai, 1986, Age-related changes in malondialdehyde content in Caryedon serratus Oliver (Coleoptera), Age, 9, 53, 10.1007/BF02432261 Rathbun, 1991, Age-related cysteine uptake as rate-limiting in glutathione synthesis and glutathione half-life in the cultured human lens, Exp. Eye Res., 53, 205, 10.1016/0014-4835(91)90075-P Ratan, 1994, Oxidative stress induces apoptosis in embryonic cortical neurons, J. Neurochem., 62, 376, 10.1046/j.1471-4159.1994.62010376.x Rechcigl, 1964, Rates and kinetics of catalase synthesis and destruction in rats fed cycad and cycasin in vivo, Fed. Proc., 23, 1376 Rechcigl, 1968, Carcinogen-mediated alteration of the rates of enzyme synthesis and degradation, Enzym. Biol. Clin., 9, 276, 10.1159/000458275 Reed, 1990, Glutathione: toxicological implications, Ann. Rev. Pharmacol. Toxicol., 30, 603, 10.1146/annurev.pa.30.040190.003131 Richie, 1986, The maintenance of high glutathione levels in healthy, very old women, Gerontologist, 26, 80A Richie, 1987, Correction of a glutathione deficiency in the aging mosquito increases its longevity, Proc. Soc. Exp. Biol. Med., 184, 113, 10.3181/00379727-184-42454 Richter, 1988, Normal oxidative damage to mitochondrial and nuclear DNA is extensive, Proc. Natl. Acad. Sci. USA, 85, 6465, 10.1073/pnas.85.17.6465 Riederer, 1989, Transition metals: ferritin, glutathione, and ascorbic acid in parkinsonian brains, J. Neurochem., 52, 515, 10.1111/j.1471-4159.1989.tb09150.x Reiter, 1995, Oxidative processes and antioxidative defense mechanisms in the aging brain, FASEB J., 9, 526, 10.1096/fasebj.9.7.7737461 Roher, 1991, β-amyloid from Alzheimer's disease brain inhibits sprouting and survival of sympathetic neurons, Biochem. Biophys. Res. Commun., 174, 572, 10.1016/0006-291X(91)91455-L Rosen, 1993, Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis, Nature, 362, 59, 10.1038/362059a0 Samuel, 1996, Neocortical Lewy body variant of Alzheimer's disease, J. Neuropathol. Exp. Neurol., 55, 44, 10.1097/00005072-199601000-00005 Sanchez-Ramos, 1994, A marker of oxyradical-mediated DNA damage (8-hydroxy-2′-deoxyguanosine) is increased in nigro-striatum of Parkinson's disease brain, Neurodegeneration, 3, 197 Sanan, 1994, Apolipoprotein E associates with β-amyloid peptide of Alzheimer's disease to form novel monofibril: isoform apo E4 associates more efficiently than apo E3, J. Clin. Invest., 94, 860, 10.1172/JCI117407 Sandri, 1990, Hydrogen peroxide production by monoamine oxidase in isolated rat brain mitochondria, its effect on glutathione levels and Ca2+ efflux, Biochim. Biophys. Acta, 1035, 300, 10.1016/0304-4165(90)90092-B Sano, 1997, A controlled trail of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease, N. Engl. J. Med., 336, 1216, 10.1056/NEJM199704243361704 Saunders, 1993, Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease, Neurology, 43, 1467, 10.1212/WNL.43.8.1467 Sayre, 1997, 4-hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease, J. Neurochem., 68, 2092, 10.1046/j.1471-4159.1997.68052092.x Schapira, 1990, Mitochondrial complex I deficiency in Parkinson's disease, J. Neurochem., 54, 823, 10.1111/j.1471-4159.1990.tb02325.x Schapira, 1990, Anatomic and disease specificity of NADH CoQ I reductase (complex I) deficiency in Parkinson's disease, J. Neurochem., 55, 2142, 10.1111/j.1471-4159.1990.tb05809.x Schmidt, 1987, Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine, J. Pharmacol. Exp. Ther., 240, 1 Schoenberg, 1986, Descriptive epidemiology of Parkinson's diseases: distribution and hypothesis formulation, Adv. Neurol., 45, 277 Schoepp, 1993, Metabotropic glutamate receptors in brain function and pathology, Trend Pharmacol. Sci., 14, 13, 10.1016/0165-6147(93)90107-U Schraufstatter, 1986, Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly (ADP-ribose) polymerase, Proc. Natl. Acad. Sci. USA, 832, 4908, 10.1073/pnas.83.13.4908 Schubert, 1995, Amyloid peptides are toxic via a common oxidative mechanism, Proc. Natl. Acad. Sci. USA, 92, 1989, 10.1073/pnas.92.6.1989 Schweers, 1995, Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments, Proc. Natl. Acad. USA, 92, 8463, 10.1073/pnas.92.18.8463 Sechi, 1996, Reduced intravenous glutathione in the treatment of early Parkinson's disease, Prog. Neuro–Psychopharmacol. Biol. Psychiatry, 20, 1159, 10.1016/S0278-5846(96)00103-0 Sharma, 1992, Peroxides in aging Zaprionus paravittiger on propyl gallate feeding, Age, 15, 45, 10.1007/BF02435022 Shaw, 1996, Glutathione-induced sodium currents in neocortex, Neuroreport, 7, 1149, 10.1097/00001756-199604260-00010 Shaw, 1995, Studies on cellular free radical protection mechanisms in the anterior horn from patients with amyotrophic lateral sclerosis, Neurodegeneration, 4, 391, 10.1006/neur.1995.0047 Shaw, 1995, Oxidative damage to protein in sporadic motor neuron disease spinal cord, Ann. Neurol., 38, 691, 10.1002/ana.410380424 H. Sheinberg, The neurotoxicity of copper, in: S. Bondy, K. Prasad (Eds.), Metal Neurotoxicity, CRC Press, Boca Raton, FL, 1988, pp. 55–60. Sian, 1994, Alterations in glutathione levels in Parkinson's disease and other neurodegenerative diseases affecting basal ganglia, Ann. Neurol., 36, 348, 10.1002/ana.410360305 J. Sian, M. Gerlach, P. Riederer, The role of altered glutathione status in the development of Parkinson's disease. in: C.A. Shaw (Ed.), Glutathione in the Nervous System, Taylor and Francis, Washington, DC, 1997, in press. H. Sies (Ed.), Oxidative Stress: Oxidants and Antioxidants, Academic Press, New York, 1991. Simonian, 1996, Oxidative stress in neurodegenerative diseases, Ann. Rev. Pharmacol. Toxicol., 36, 83, 10.1146/annurev.pa.36.040196.000503 Simonian, 1993, Functional alterations in Alzheimer's disease: diminution of cytochrome oxidase in hippocampal formation, J. Neuropath. Exp. Neurol., 52, 580, 10.1097/00005072-199311000-00004 Slivka, 1987, Reduced and oxidized glutathione in human and monkey brain, Neurosci. Lett., 74, 112, 10.1016/0304-3940(87)90061-9 Smale, 1995, Evidence for apoptotic cell death in Alzheimer's disease, Exp. Neurol., 133, 225, 10.1006/exnr.1995.1025 Smith, 1966, Mutagenicity of cycasin aglycone (methylazoxymethanol), a naturally occurring carcinogen, Science, 152, 1273, 10.1126/science.152.3726.1273 Smith, 1995, Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease, J. Neurochem., 64, 2660, 10.1046/j.1471-4159.1995.64062660.x Sohal, 1981, Effect of age and metabolic rate on lipid peroxidation in the housefly, Musca domestica, Mech. Ageing Dev., 16, 159, 10.1016/0047-6374(81)90092-0 Sohal, 1984, Effect of age on oxygen consumption, superoxide dismutase, catalase, glutathione, inorganic peroxide and chloroform-soluble antioxidants in the adult male housefly, Musca domestica, Mech. Ageing Dev., 24, 185, 10.1016/0047-6374(84)90070-8 R.S. Sohal, W.C. Orr, Is oxidative stress a causal factor in aging?, in: K. Esser, G.M. Martin (Eds.), Molecular Aspects of Aging, Wiley, New York, 1995, pp. 109–126. Sofic, 1991, Selective increase of substantia nigra zona compacta of Parkinsonian brains, J. Neurochem., 56, 978, 10.1111/j.1471-4159.1991.tb02017.x Sohal, 1996, Oxidative stress, caloric restriction, and aging, Science, 273, 59, 10.1126/science.273.5271.59 Spatz, 1968, Evidence for transplacental passage of the natural carcinogen cycasin and its aglycone, Proc. Soc. Exp. Biol. Med., 127, 281, 10.3181/00379727-127-32672 Spencer, 1987, Guam amyotrophic lateral sclerosis–parkinsonism–dementia linked to a plant excitant neurotoxin, Science, 237, 517, 10.1126/science.3603037 Spina, 1989, Dopamine turnover and glutathione oxidation: implications for Parkinson's disease, Proc. Natl. Acad. USA, 86, 1398, 10.1073/pnas.86.4.1398 Stemmer, 1991, Serine/threonine phosphatases in the nervous system, Curr. Opinion Neurobiol., 1, 53, 10.1016/0959-4388(91)90010-5 Strittmatter, 1993, Binding of human apolipoprotein E to synthetic β peptide: isoform-specific effects and implications for late-onset Alzheimer's disease, Proc. Natl. Acad. USA, 90, 8098, 10.1073/pnas.90.17.8098 H.M. Swartz, K. Mader, Free radicals in aging: Theories, facts and artifacts, in: K. Esser, G.M. Martin (Eds.), Molecular Aspects of Aging, Wiley, New York, 1995, pp. 77–97. Tariot, 1994, Alzheimer disease: an overview, Alz. Dis. Assoc. Disord., 8, S4, 10.1097/00002093-199424000-00002 Talley, 1995, Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by antioxidant N-acetylcysteine and the genes Bcl-2 and crmA, Mol. Cell. Biol., 15, 2359, 10.1128/MCB.15.5.2359 Toborek, 1994, Fatty acid-mediated effects on the glutathione redox cycle in cultured endothelial cells, Am. J. Clin. Nutr., 59, 60, 10.1093/ajcn/59.1.60 Toffa, 1997, Glutathione depletion in rat brain does not cause nigrostriatal pathway degeneration, J. Neural Transm., 104, 67, 10.1007/BF01271295 Troncoso, 1993, In vitro polymerization of oxidized tau into filaments, Brain Res., 613, 313, 10.1016/0006-8993(93)90918-D van Duijn, 1994, Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease, Nature Genet., 7, 74, 10.1038/ng0594-74 Varga, 1997, Glutathione is an endogenous ligand of rat brain N-methyl-d-aspartate (NMDA) and 2-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors, Neurochem. Res., 22, 1165, 10.1023/A:1027377605054 Volterra, 1994, Glutamate uptake inhibition by oxygen free radicals in rat brain cortical astrocytes, J. Neurochem., 14, 2924 von Poppe, 1963, Klinische und pathologisch–anatomische Untersuchungen uber Kombinations formen praseniler Hirnatrophien (Pick, Alzheimer) mit spinalen atrophisierenden Prozessen, Psychiatr. Neurol., 145, 322, 10.1159/000128984 Wagey, 1994, Abnormal phosphorylation activity in the pathogenesis of ALS, Soc. Neurosci. Abstr., 20, 1648 R. Wagey, C. Krieger, C.A. Shaw, Abnormal dephosphorylation effect on NMDA receptor regulation in ALS spinal cord, Neurobiol. Dis., (1997), in press. Ward, 1977, Molecular mechanisms of radiation-induced damage to nucleic acids, Adv. Radiat. Biol., 5, 181, 10.1016/B978-0-12-035405-4.50011-6 Warner, 1994, Superoxide dismutase, aging, and degenerative disease, Free Rad. Biol. Med., 17, 249, 10.1016/0891-5849(94)90080-9 Watkins, 1987, Agonists and antagonists for excitatory amino acids, Trends Neurosci., 10, 265, 10.1016/0166-2236(87)90171-8 Wei, 1996, Genetic elevation of monoamine oxidase levels in dopaminergic PC12 cells results in increased free radical damage and sensitivity to MPTP, J. Neurosci. Res., 46, 666, 10.1002/(SICI)1097-4547(19961215)46:6<666::AID-JNR3>3.0.CO;2-D Weinstock, 1995, The pharmacotherapy of Alzheimer's disease based on the cholinergic hypothesis: an update, Neurodegeneration, 4, 349, 10.1006/neur.1995.0042 Whetsell, 1996, Current concepts of excitotoxicity, J. Neuropathol. Exp. Neurol., 55, 1, 10.1097/00005072-199601000-00001 Whiting, 1963, Toxicity of cycads, Econ. Botany, 17, 271, 10.1007/BF02860136 Williams, 1991, Motor neuron disease (amyotrophic lateral sclerosis), Mayo Clin. Proc., 66, 54, 10.1016/S0025-6196(12)61175-6 Willmore, 1991, Iron-induced lipid peroxidation and brain injury responses, Int. J. Dev. Neurosci., 9, 175, 10.1016/0736-5748(91)90009-B Wong, 1995, An adverse property of a familial ALS-linked SOD 1 mutation causes motor neuron disease, Neuron, 14, 1105, 10.1016/0896-6273(95)90259-7 Wu, 1994, Protection of nigral neurons against MPP+-induced oxidative injury by deprenyl (selegiline), U-78517F, and DMSO, N. Trends Clin. Neuropharmacol., 8, 187 Wullner, 1996, Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurones, Neuroreport, 7, 921, 10.1097/00001756-199603220-00018 J.L. Yakel, Calcineurin regulation of synaptic function: from ion channels to transmitter release and gene transcription, Trends Pharmacol. Sci., (1997) 124–134. Yamamoto, 1993, Protective actions of YM737, a new glutathione analog. against cerebral ischemia in rats, Res. Commun. Chem. Pathol. Pharmacol., 81, 221 Yan, 1996, RAGE and amyloid β peptide neurotoxicity in Alzheimer's disease, Nature, 382, 685, 10.1038/382685a0 Yan, 1994, Glycated tau protein in Alzheimer's disease: a mechanism for induction of oxidative stress, Proc. Natl. Acad. Sci. USA, 91, 7787, 10.1073/pnas.91.16.7787 S.-D. Yan, S.F. Yan, X. Chen, J. Fu, M. Chen, P. Kuppusamy, M. Smith, G. Perry, G.C. Godman, P. Nawroth, J.L. Zweier, D. Stern, Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide, Nature Med., (1995) 693–699. Yanagihara, 1984, Calcium and vitamin D metabolism in Guamanian Chamorros with amyotrophic lateral sclerosis and parkinsonism–dementia, Ann. Neurol., 15, 42, 10.1002/ana.410150108 Yankner, 1996, Mechanisms of neuronal degeneration in Alzheimer's disease, Neuron, 16, 921, 10.1016/S0896-6273(00)80115-4 Yankner, 1989, Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease, Science, 245, 417, 10.1126/science.2474201 Yoshikawa, 1967, Lipid peroxide formation in the brain of aging rats, J. Gerontol., 22, 162, 10.1093/geronj/22.2.162 Youdim, 1997, Understanding Parkinson's disease, Sci. Am., 276, 52, 10.1038/scientificamerican0197-52 Zaczek, 1989, Methylphenidate and pemoline do not cause depletion of rat brain monoamine markers similar to that observed with methamphetamine, Toxicol. Appl. Pharmacol., 100, 227, 10.1016/0041-008X(89)90309-8 Zaleska, 1985, Regional lipid peroxidation in rat brain in vitro: possible role of endogenous iron, Neurochem. Res., 10, 397, 10.1007/BF00964608 K. Zaman, R. Ratan, Glutathione and the regulation of apoptosis in the nervous system, in: C.A. Shaw (Ed.), Glutathione in the Nervous System, Taylor and Francis, Washington, DC, 1997, in press. Zatta, 1992, The identification of aluminum (III) in the core of mature plaques from Alzheimer's disease, Neurobiol. Aging, 13, S117 Zeevalk, 1990, Mechanisms underlying initiation of excitotoxicity associated with metabolic inhibition, J. Pharmacol. Exp. Ther., 257, 870 Zhang, 1996, Amyloid β-mediated oxidative and metabolic stress in rat cortical neurons: no evidence for a role for H2O2 generation, J. Neurochem., 67, 1595, 10.1046/j.1471-4159.1996.67041595.x